Board Appointment
2008年4月10日 - 8:47PM
RNSを含む英国規制内ニュース (英語)
RNS Number:0717S
Arthro Kinetics plc
10 April 2008
Press Release
Board Appointment
THURSDAY, 10th April 2008 - Arthro Kinetics plc (AIM: AKI) ("Arthro Kinetics" or
"the Company"), the orthopedics company dedicated to regenerating joint mobility
and spinal disc function announces the appointment of Professor Dr. Ulrich
Wolfgang Peter Abshagen (age 64) as a non-executive director with immediate
effect.
Professor Abshagen is a founder and managing partner of Heidelberg Innovation
GmbH, the European venture capital group that has a holding of approximately 56%
of the issued share capital of the Company. Prior to Heidelberg Innovation,
Professor Abshagen served as president and chief executive for the
pharmaceutical business of Boehringer Mannheim GmbH, now part of Roche Group.
Current directorships
Heidelberg Innovation Group, Venture Capital
Heidelberg Innovation GmbH
Heidelberg Innovation Asset Management GmbH& Co. KG
Heidelberg Innovation Asset Management GmbH
Heidelberg Innovation Asset Management GbR
Heidelberg Innovation Fonds Management GmbH
Heidelberg Innovation Parallel-Beteiligungs GmbH&Co.KGaA
Abshagen Consulting GmbH
HBM BioVentures AG
invendo Medical GmbH
Digilab, Inc
Directorships held during the previous five years
Biofrontera AG (2005-2007)
Alantos Pharmaceuticals AG (2000-2007)
mtm Laboratories AG (1999-2006)
febit AG (1999-2004)
Munich Biotech AG (2001-2004)
Heidelberg Pharma GmbH (1999-2004)
Atec Dr. Mann GmbH (1999-2003)
Abeta GmbH (now The Genetics Company) (2000-2003)
Berlin Heart AG (now Berlin Heart GmbH) (2006)
Professor Abshagen was a director of Atec Dr.Mann GmbH, Heidelberg Pharma GmbH,
febit AG and Munich Biotech AG all of which became insolvent and were put into
receivership between 2002 and 2004.
Professor Abshagen holds 100,000 Ordinary Shares in the Company, representing
approximately 0.1 per cent of the issued share capital.
There is no further information to be disclosed under Schedule 2(g) of the AIM
Rules.
CONTACTS
Arthro Kinetics Plc Tel: +49 (0)711 305 110 70
Jason Loveridge, Chief Executive Officer
Doug Quinn, Chief Financial Officer
Nomura Code Securities Limited Tel: +44 (0)207 776 1200
Clare Terlouw
END
This information is provided by RNS
The company news service from the London Stock Exchange
END
BOABBGDSXSBGGIG
Arthro Kinetics (LSE:AKI)
過去 株価チャート
から 5 2024 まで 6 2024
Arthro Kinetics (LSE:AKI)
過去 株価チャート
から 6 2023 まで 6 2024
Real-Time news about Arthro Kinetics (ロンドン証券取引所): 0 recent articles
その他のArthro Kinetics Plcニュース記事